Related Experiment Video
Updated: Nov 15, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions
Feng Wang1, Bryant Chau1, Sean M West1
1Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA.
Abstract:
Glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) and GITR ligand (GITRL) are members of the tumor necrosis superfamily that play a role in immune cell signaling, activation, and survival. GITR is a therapeutic target for directly activating effector CD4 and CD8 T cells, or depleting GITR-expressing regulatory T cells (Tregs), thereby promoting anti-tumor immune responses. GITR activation through its native ligand is important for understanding immune signaling, but GITR structure has not been reported. Here we present structures of human and mouse GITR receptors bound to their cognate ligands. Both species share a receptor-ligand interface and receptor-receptor interface; the unique C-terminal receptor-receptor enables higher order structures on the membrane. Human GITR-GITRL has potential to form a hexameric network of membrane complexes, while murine GITR-GITRL complex forms a linear chain due to dimeric interactions. Mutations at the receptor-receptor interface in human GITR reduce cell signaling with in vitro ligand binding assays and minimize higher order membrane structures when bound by fluorescently labeled ligand in cell imaging experiments.
Insights
Glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand (GITRL) structures reveal how they interact on cell surfaces. These findings are crucial for developing new immunotherapies targeting cancer.
Area of Science:
- Immunology
- Structural Biology
- Biochemistry
Background:
- Glucocorticoid-induced tumor necrosis factor receptor (GITR) and GITR ligand (GITRL) are key regulators of immune responses within the tumor necrosis superfamily.
- GITR is a therapeutic target for modulating T cell activity and promoting anti-tumor immunity.
- Understanding the structural basis of GITR-GITRL interaction is essential for designing effective immunotherapies.
Purpose of the Study:
- To determine the structures of human and mouse GITR receptors bound to their cognate ligands.
- To elucidate the molecular mechanisms underlying GITR-GITRL interactions and higher-order complex formation.
- To investigate the functional consequences of altering the GITR-GITRL interface on cell signaling.
Main Methods:
- X-ray crystallography to determine the structures of GITR-GITRL complexes.
- In vitro ligand binding assays to assess the impact of interface mutations on binding affinity.
- Cell imaging experiments using fluorescently labeled ligands to visualize membrane complex formation.
Main Results:
- The structures reveal conserved receptor-ligand and receptor-receptor interfaces between human and mouse GITR-GITRL complexes.
- Human GITR-GITRL can form hexameric membrane networks, while murine GITR-GITRL forms linear chains.
- Mutations at the human GITR receptor-receptor interface decrease cell signaling and higher-order membrane structure formation.
Conclusions:
- The unique C-terminal receptor-receptor interface enables distinct higher-order structures of GITR-GITRL complexes on cell membranes.
- These structural insights provide a foundation for developing targeted therapies that modulate GITR signaling for cancer treatment.
- Understanding the species-specific assembly of GITR-GITRL complexes is critical for preclinical translation of GITR-based immunotherapies.
More Related Videos
13:36Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT
Published on: September 30, 2010
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
Related Concept Videos
TGF - β Signaling Pathway
General Transcription Factors